$ARMP News

Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update

Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02

Armata Pharmaceuticals Granted FDA's Fast Track Designation For AP-SA02 To Treat Bacterial Infections

Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology"

Armata Pharmaceutics Announces Publication Of Paper In 'Communications Biology,' A Peer-Reviewed Journal From Nature Portfolio

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results

Armata Pharmaceuticals Q4 EPS $(3.43) Misses $(0.28) Estimate, Sales $1.085M Beat $750.000K Estimate

Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update

Armata Pharmaceuticals To Delay Announcement Of Q4, FY25 Financial Results; Provides Corporate Update

Armata Pharmaceuticals: Intriguing Antibiotic Adjunct, But Too Many Potential Red Flags

H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $15

Armata Pharmaceuticals AP-SA02 Gains FDA QIDP Designation Unlocking Five-Year Market Exclusivity And Fast Track Eligibility For S. Aureus Bacteremia

Armata Pharmaceuticals AP-SA02 Gains FDA QIDP Designation Unlocking Five-Year Market Exclusivity And Fast Track Eligibility For S. Aureus Bacteremia

/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting With FDA; FDA Agreed That Data From Phase 2a diSArm Study Support Advancement Of P-SA02 To Phase 3

Jones Trading Initiates Coverage On Armata Pharmaceuticals with Buy Rating, Announces Price Target of $15

Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST